extravasation

Zolmitriptan (311C90) 是一种5-HT1B 1D 受体部分激动剂，可用于偏头痛的研究，对 5-HT1B、5-HT1D、5-HT1F 受体的Ki 分别为 5.01、0.63 和 63.09 nM。

BF-1是一种新型选择性 5-HT2 受体拮抗剂，通过阻断间氯苯基哌嗪 （mCPP） 或BW723C86诱导的神经源性硬脑膜血浆蛋白外渗发挥作用。BF-1 可用于研究偏头痛。

N-Acetylneuraminic acid (Acide aceneuramique) 是一种九碳唾液酸单糖，通常存在于细胞膜上的糖蛋白和哺乳动物细胞中的神经节苷脂等糖脂中。它可用于神经传递、白细胞外渗、病毒或细菌感染以及碳水化合物-蛋白质识别。

5'-N-Ethylcarboxamidoadenosine (NECA) 是腺苷受体的激动剂，可增加荧光素和低分子量葡聚糖的脑外渗，与血脑屏障调节无关。

CP-122288 is a potent and selective agonist for the 5-HT1B, 5-HT1D and 5-HT1F serotonin receptor subtypes. CP-122288 is potent as an inhibitor of plasma protein extravasation and neurogenic inflammation.

PNU109291, a potent and selective agonist of the 5-HT1D receptor, effectively mitigates dural plasma extravasation induced by trigeminal ganglion stimulation.

GW833972 is a CB2 Agonist. GW 833972A inhibited capsaicin-induced depolarization of the human and guinea-pig and prostaglandin E(2) (PGE(2)) and hypertonic saline-induced depolarization of the guinea-pig isolated vagus nerve in vitro. GW 833972A also inhibited citric acid-induced cough but not plasma extravasation in the guinea-pig and this effect was blocked by a CB(2) receptor antagonist.

4991W93 is a 5HT(1B 1D) receptor partial agonist, inhibiting electrically induced plasma extravasation, blocking neurogenic plasma protein extravasation, inhibiting release of calcitonin gene-related peptide.

Enlimomab (BI-RR 0001) 是一种针对人 ICAM-1的小鼠 IgG2a 单抗，可抑制白细胞粘附到血管内皮，从而减少白细胞外渗漏和炎症性组织损伤。Enlimomab 具有抗炎作用，可用于中风研究。

Ac2-12 TFA是抑制嗜中性白细胞外渗的膜联蛋白 脂皮质激素1(LC1)模拟肽，具有抗迁移特性，能在实验性炎症模型中阻止嗜中性白细胞的募集。

Annexin/lipocortin 1-mimetic peptide; inhibits leukocyte extravasation. Reduces neutrophil adhesion and emigration, and promotes detachment of neutrophils from activated mesenteric endothelium in mice in vivo.

N-terminal peptide of Annexin I (AI/Lipocortin I) that inhibits leukocyte extravasation. Acts as a formyl peptide receptor 1 (FPR1) ligand and stimulates neutrophil NADPH oxidase activation.

Urotensin-II (UT) receptor ligand; behaves as a silent antagonist in most in vitro assays and in vivo, but does retain small residual agonist activity under certain conditions in some assays. Competitively antagonizes U-II induced contractions in the rat